Copyright
©The Author(s) 2023.
World J Diabetes. Nov 15, 2023; 14(11): 1672-1692
Published online Nov 15, 2023. doi: 10.4239/wjd.v14.i11.1672
Published online Nov 15, 2023. doi: 10.4239/wjd.v14.i11.1672
Figure 2 The structure of drug active ingredient.
A: Beta-glycyrrhetinic acid; B: Alpha-glycyrrhetinic acid.
- Citation: Meng FD, Yuan L, Xu DJ, Che MY, Hou SZ, Lu DD, Liu WJ, Nan Y. Exploring the targets and molecular mechanism of glycyrrhetinic acid against diabetic nephropathy based on network pharmacology and molecular docking. World J Diabetes 2023; 14(11): 1672-1692
- URL: https://www.wjgnet.com/1948-9358/full/v14/i11/1672.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i11.1672